An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Drug Gaining Traction Online
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors market the drug there before directing buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Professionals Express Concerns
However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.
Several experts said the popularity for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and customer laws, risking penalties, legal action or prison.
Service Response and Material Elimination
According to the social media company, the platform has taken down violative content and banned related keywords and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Research also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for preparing or administering at residence.
Within moments of entering one group, a vendor posted WhatsApp details, where most purchases occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.
Product Details and Pricing
Within these communities, posts display dark colored packages with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A representative for Telegram said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has previously seen individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject users to possibly significant medical dangers”.
